TipRanks
Tue, December 30, 2025 astatine 7:05 AM CST 1 min read
Azenta (AZTA) announced that its affiliate, Azenta Germany, has signed a binding statement for the merchantability of Azenta’s B Medical Systems concern to THELEMA S.A R.L., for a acquisition terms of $63M. The transaction is expected to adjacent connected oregon earlier March 31, 2026. “The statement to merchantability B Medical Systems marks a large measurement guardant successful simplifying the portfolio to prioritize our halfway capabilities with the highest strategical impact,” said John Marotta, President and CEO. “The proceeds from this merchantability volition beryllium deployed to fortify the institution and thrust semipermanent profitable worth instauration for our shareholders.”
-
Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
-
Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential
Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>
See today’s best-performing stocks connected TipRanks >>
Read More connected AZTA:
Disclaimer & DisclosureReport an Issue
-
Azenta terms people raised to $44 from $42 astatine Needham
-
Azenta Announces $250 Million Share Repurchase Program
-
Azenta authorizes $250M stock repurchase program
-
Azenta to big capitalist day
-
Azenta Delays 10-K Filing Due to Accounting Revisions

20 hours ago
1





English (CA) ·
English (US) ·
Spanish (MX) ·